Apple Watch to Launch FDA-Cleared Hypertension Detection Feature
Apple is set to introduce a groundbreaking health feature on its smartwatches next week—FDA-cleared hypertension detection. The tool, available across 150 regions including the U.S. and EU, leverages optical heart sensors to monitor blood vessel responses over 30 days, flagging early signs of chronic high blood pressure. This rollout underscores Apple's expanding influence in digital health.
The FDA clearance contrasts sharply with regulatory challenges faced by competitors like WHOOP, highlighting the critical role of clinical validation in health tech. Compatible with the latest Apple Watch models, including Series 9-11 and Ultra 2-3, the feature taps into the booming wearable health market, projected to surpass $160 billion by 2030.